Stock · APOLLOHOSP · Healthcare
APOLLOHOSP share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for APOLLO HOSPITALS ENTERPRISE LIMITED, refreshed every end-of-day run. A systematic, data-only read on APOLLO HOSPITALS ENTERPRISE LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
The verdict
BazaarBaazi reads APOLLOHOSP as constructive with a Crack Score of 98/100 as of 21 Jul 2026.
BazaarBaaziSource & method
The scanner's readScanned · scanned 21 Jul 2026
Where APOLLOHOSP stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.
Scanned and scored this run, but the evidence is incomplete or conflicted. The engine fails closed to NO_TRADE.
Technical axis
100/100Fundamental axis
20/100Money flow
77/100Result pulse · Q4 FY26
0/100Technical evidence
price above 50DMA
price above 150DMA
price above 200DMA
50 > 150 > 200 DMA (clean stack)
money-flow score 77.2/100
up/down volume 1.69x (buyers dominant)
MFI 64.5
net +8 accumulation days (25d)
Red flags
above 200DMA (not a confirmed short-side trend)
strong accumulation tape
weak filed result (score 0.0)
Relative valuation
P/E (TTM)
66.1P/E vs sector
+1.3%Sector percentile
68PEG
n/aScanner levels from the deterministic engine run of 2026-07-21, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.
Price target: support and resistanceComputed 21 Jul 2026
Support and resistance for APOLLOHOSP are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the APOLLOHOSP chart, refreshed every end-of-day run.
The Crack Score, and how it is built98 / 100 · High conviction
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for APOLLOHOSP, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
About APOLLO HOSPITALS ENTERPRISE LIMITEDBusiness profile
What APOLLOHOSP actually does, and the edge that holds its position.
Apollo is two stocks wearing one ticker: a high-quality, cash-generating hospital chain, and a loss-making digital-pharmacy bet the market keeps arguing about. It is India's largest integrated private healthcare network, running multi-specialty hospitals, primary care clinics, pharmacies and digital platforms, with over 70 hospitals across India and some international markets, concentrated in the South where it began. Around the hospitals sit Apollo Health and Lifestyle in primary care and diagnostics, Apollo Pharmacy as one of India's largest pharmacy chains, and Apollo HealthCo, the digital and pharmacy-led platform that swings the consolidated story.
Apollo's moat is the trust and clinical reputation built over four decades as the institution that brought corporate tertiary healthcare to India. The brand commands referrals from doctors, patients and medical tourism visitors across South and Southeast Asia who specifically seek the Apollo name for complex procedures. The pharmacy network's scale creates both a distribution moat and a patient-data advantage for the digital health platform.
The F&O viewHorizon · swing
How the futures and options structure on APOLLOHOSP reads right now.
The editorial price read on APOLLOHOSP is bullish. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on APOLLOHOSP can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving APOLLOHOSP.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 21 Jul 2026. Why APOLLOHOSP moved, the living explainer, tracks every move on one URL.
The 2026 to 2030 pictureStructural read
What genuinely drives APOLLOHOSP over a multi-year horizon. A structural read, not a price forecast.
Between 2026 and 2030, India's private healthcare expenditure is structurally expanding as health insurance penetration rises and the middle class increasingly prefers organised hospital care over government facilities. Apollo's growth levers are new hospital capacity coming onstream in underpenetrated cities, Apollo HealthCo scaling as a digital health and pharmacy superapp, and international medical tourism recovering and growing. The key risk is regulatory intervention on healthcare pricing or a sharp increase in competition from funded hospital chains compressing occupancy in key markets. What BazaarBaazi thinks: the hospital franchise and the insurance-led demand wave are a genuine structural story, but the drag no score isolates is HealthCo, the digital arm can keep consuming cash and weighing on consolidated margins long after the hospitals are performing, so the read on Apollo is really a read on how patient you are with the loss-making half.
What to watch:
- Average revenue per occupied bed across the hospital network
- Occupancy rates in newly commissioned hospitals as they ramp
- Apollo HealthCo digital platform active users and monetisation progress
- Apollo Pharmacy same-store sales growth and network expansion
- International patient revenue as a barometer of medical tourism recovery
Peers and how to compare4 listed names
The listed names APOLLOHOSP is most often read against. Compare them on the same Crack Score and levels.
Fortis Healthcare
Listed peer in the same space
Max Healthcare Institute
Listed peer in the same space
Narayana Hrudayalaya
Listed peer in the same space
Manipal Hospitals (private)
Listed peer in the same space
Live valuation readQ4 FY26 earnings · live spot
P/E, P/B, yield and the quality set for APOLLO HOSPITALS ENTERPRISE LIMITED, computed from the latest filed results times the live spot. The price-driven ratios (marked) refresh every session; ROE and margins hold until the next results.
P / E
65.9x
Earnings yield
1.52%
P / B
13.54x
P / S
5.09x
EV / EBITDA
35.7x
Dividend yield
0.22%
Market cap
Rs 1.28 lakh cr
Enterprise value
Rs 1.35 lakh cr
Stored from APOLLO HOSPITALS ENTERPRISE LIMITED's filed results, as of 2026-07-21 and currency-checked. Price input Rs 8,926.50 from baked EOD spot. Open the calculator, move the price and watch every ratio react.
Latest filed resultsQ4 FY26
APOLLO HOSPITALS ENTERPRISE LIMITED's most recent quarter, parsed straight from the official BSE filing. Every figure links back to its primary source.
Result Pulse
0 / 100Revenue
Rs 6,606 crNet profit
Rs 551 crEPS (quarter)
Rs 36.82| Growth | YoY | QoQ |
|---|---|---|
| Revenue | n/a | n/a |
| Net profit | n/a | n/a |
| Net margin | n/a | |
Figures are the Q4 FY26 result for APOLLO HOSPITALS ENTERPRISE LIMITED, parsed straight from the official BSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Earnings history, every filed quarter32 quarters on record
APOLLO HOSPITALS ENTERPRISE LIMITED's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 30 Jun 2018. These are quarterly facts, not TTM valuation inputs.
APOLLOHOSP official result trail
32 quarters
Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.
| Quarter | Revenue | EPS | PAT YoY | Pulse | Source |
|---|---|---|---|---|---|
| Q4 FY26ended 31 Mar 2026 / Consolidated, audited | Rs 6,606 cr | Rs 36.82 | n/a | n/a | Filing |
| Q3 FY26ended 31 Dec 2025 / Consolidated, audited | Rs 6,477 cr | Rs 34.94 | n/a | 50/100 | Filing |
| Q2 FY26ended 30 Sep 2025 / Consolidated, audited | Rs 6,304 cr | Rs 33.19 | n/a | 56/100 | Filing |
| Q1 FY26ended 30 Jun 2025 / Consolidated, audited | Rs 5,842 cr | Rs 30.10 | n/a | 50/100 | Filing |
| Q4 FY25ended 31 Mar 2025 / Consolidated, audited | Rs 5,592 cr | Rs 27.10 | n/a | n/a | Filing |
| Q3 FY25ended 31 Dec 2024 / Consolidated, audited | Rs 5,527 cr | Rs 25.89 | n/a | n/a | Filing |
| Q2 FY25ended 30 Sep 2024 / Consolidated, audited | Rs 5,589 cr | Rs 26.34 | n/a | n/a | Filing |
| Q1 FY25ended 30 Jun 2024 / Consolidated, audited | Rs 5,086 cr | Rs 21.23 | n/a | n/a | Filing |
| Q4 FY24ended 31 Mar 2024 / Consolidated, audited | Rs 4,944 cr | Rs 17.65 | n/a | n/a | Filing |
| Q3 FY24ended 31 Dec 2023 / Consolidated, audited | Rs 4,851 cr | Rs 17.06 | n/a | n/a | Filing |
| Q2 FY24ended 30 Sep 2023 / Consolidated, audited | Rs 4,847 cr | Rs 16.20 | n/a | n/a | Filing |
| Q1 FY24ended 30 Jun 2023 / Consolidated, audited | Rs 4,418 cr | Rs 11.59 | n/a | n/a | Filing |
| Q4 FY23ended 31 Mar 2023 / Consolidated, audited | Rs 4,302 cr | Rs 10.05 | n/a | n/a | Filing |
| Q3 FY23ended 31 Dec 2022 / Consolidated, audited | Rs 4,264 cr | Rs 10.67 | n/a | n/a | Filing |
| Q2 FY23ended 30 Sep 2022 / Consolidated, audited | Rs 4,251 cr | Rs 14.19 | n/a | n/a | Filing |
| Q1 FY23ended 30 Jun 2022 / Consolidated, audited | Rs 3,796 cr | Rs 22.05 | n/a | n/a | Filing |
| Q4 FY22ended 31 Mar 2022 / Consolidated, audited | Rs 3,546 cr | Rs 6.27 | n/a | n/a | Filing |
| Q3 FY22ended 31 Dec 2021 / Consolidated, audited | Rs 3,639 cr | Rs 15.88 | n/a | n/a | Filing |
| Q2 FY22ended 30 Sep 2021 / Consolidated, audited | Rs 3,717 cr | Rs 17.24 | n/a | n/a | Filing |
| Q1 FY22ended 30 Jun 2021 / Consolidated, audited | Rs 3,760 cr | Rs 34.03 | n/a | n/a | Filing |
| Q4 FY21ended 31 Mar 2021 / Consolidated, audited | Rs 2,868 cr | Rs 11.77 | n/a | n/a | Filing |
| Q3 FY21ended 31 Dec 2020 / Consolidated, audited | Rs 2,760 cr | Rs 9.38 | n/a | n/a | Filing |
| Q2 FY21ended 30 Sep 2020 / Consolidated, audited | Rs 2,761 cr | Rs 4.33 | n/a | n/a | Filing |
| Q1 FY21ended 30 Jun 2020 / Consolidated, audited | Rs 2,172 cr | Rs -14.97 | n/a | n/a | Filing |
| Q4 FY20ended 31 Mar 2020 / Consolidated, audited | Rs 2,922 cr | Rs 15.77 | n/a | n/a | Filing |
| Q3 FY20ended 31 Dec 2019 / Standalone, audited | Rs 2,530 cr | Rs 6.81 | n/a | n/a | Filing |
| Q2 FY20ended 30 Sep 2019 / Consolidated, audited | Rs 2,841 cr | Rs 6.20 | n/a | n/a | Filing |
| Q1 FY20ended 30 Jun 2019 / Consolidated, audited | Rs 2,572 cr | Rs 4.11 | n/a | n/a | Filing |
| Q4 FY19ended 31 Mar 2019 / Standalone, audited | Rs 2,167 cr | Rs 5.51 | n/a | n/a | Filing |
| Q3 FY19ended 31 Dec 2018 / Standalone, audited | Rs 2,169 cr | Rs 6.25 | n/a | n/a | Filing |
| Q2 FY19ended 30 Sep 2018 / Standalone, audited | Rs 2,090 cr | Rs 5.68 | n/a | n/a | Filing |
| Q1 FY19ended 30 Jun 2018 / Standalone, audited | Rs 1,910 cr | Rs 4.32 | n/a | n/a | Filing |
The official financialsFiled to 31 Mar 2026
APOLLO HOSPITALS ENTERPRISE LIMITED's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.
Trailing twelve months, on filed quarters
Revenue (TTM)
25,229 crNet profit (TTM)
2,003 crEBIT (TTM)
3,066 crProfit before tax (TTM)
2,616 crNet margin (TTM)
7.9%Finance costs (TTM)
450 crBalance sheet, as filed 2026-03-31
Total assets
22,197 crShareholder equity
9,975 crTotal borrowings
5,659 crCash and equivalents
811 crInventory
542 crTrade receivables
3,485 crThe cash engine, latest filed year
Operating cash flow
2,856 crCapex
1,962 crFree cash flow
894 crInvesting flow
2,148 crFinancing flow
478 crAnnual trail, filed year over filed year
| Year | Revenue | Net profit | Equity | Borrowings | CFO |
|---|---|---|---|---|---|
| FY26 | 25,229 cr | 2,003 cr | 9,975 cr | 5,659 cr | 2,856 cr |
| FY25 | 21,794 cr | 1,505 cr | 8,653 cr | 5,275 cr | 2,136 cr |
| FY24 | 19,059 cr | 935 cr | 7,321 cr | 3,162 cr | 1,920 cr |
| FY23 | 16,612 cr | 845 cr | 6,531 cr | 2,710 cr | 1,377 cr |
| FY22 | 14,663 cr | 1,108 cr | 5,899 cr | 2,636 cr | 1,616 cr |
| FY21 | 10,560 cr | 137 cr | 4,803 cr | 2,495 cr | n/a |
Every figure is parsed from APOLLO HOSPITALS ENTERPRISE LIMITED's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.
Management on record27 earnings calls
Every APOLLOHOSP earnings call BazaarBaazi has indexed, latest 28 Feb 2026. Read management in its own words, straight from the filed transcript.
APOLLO HOSPITALS ENTERPRISE LIMITED earnings calls on record
27 calls since 28 Feb 2018
Show 19 older calls
Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.
What changed50 disclosures
Every recent official filing from APOLLO HOSPITALS ENTERPRISE LIMITED, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.
APOLLO HOSPITALS ENTERPRISE LIMITED has filed 50 official disclosures recently. The most recent is a Investor meet dated 18 Jul 2026.
Event Heat
62 / 100Certificate under Regulation 74(5) for the period ended 30th June 2026
the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Proceedings of Court Convened General Meeting held on Jun 24, 2026 along with a copy of minutes
Event Heat is a dated net read of APOLLO HOSPITALS ENTERPRISE LIMITED's last 90 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the APOLLOHOSP chart. Not a substitute for a registered research note.
| Ticker | APOLLOHOSP |
|---|---|
| Full name | APOLLO HOSPITALS ENTERPRISE LIMITED |
| Sector | Healthcare |
| Index class | LARGE CAP |
| ISIN | INE437A01024 |
| Market-cap band | ~1.3 lakh cr (indicative) |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 21 Jul 2026 |
| Aliases tracked | APOLLOHOSP |
Reference chartLevels in show
The daily frame the desk reads on APOLLOHOSP.
FAQ17 reader questions · AEO-eligible
The line on APOLLOHOSP, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the APOLLOHOSP share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on APOLLOHOSP. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.
What is BazaarBaazi's Crack Score for APOLLOHOSP?
The BazaarBaazi Crack Score for APOLLOHOSP is 98 out of 100 as of 21 Jul 2026, a high conviction reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on APOLLOHOSP?
Strike-level option inventory for APOLLOHOSP is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.
What sector is APOLLOHOSP in and which peers does BazaarBaazi track?
APOLLOHOSP sits in Healthcare (large cap), indicative market cap ~1.3 lakh cr (indicative), ISIN INE437A01024. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on APOLLO HOSPITALS ENTERPRISE LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
How often is the APOLLOHOSP view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on APOLLOHOSP is bullish, published in Systematic Read on 21 Jul 2026.
Is Apollo Hospitals a good long-term stock?
The case is a structural demand story of rising per-capita healthcare spend flowing to private hospitals, but the risk no score captures is the HealthCo digital arm draining cash and consolidated margins while the hospitals quietly do the heavy lifting. BazaarBaazi's Crack Score for APOLLOHOSP gives the current dated structural read. The long-term view depends on bed-addition execution and HealthCo's digital monetisation.
Apollo Hospitals share price target 2030?
What drives APOLLOHOSP through 2030 is new hospital ramp, insurance-led volume growth and pharmacy expansion, with the catch that HealthCo must turn from cash drain to contributor for the consolidated picture to re-rate, which no target can assume. BazaarBaazi does not publish fixed multi-year targets. The live Crack Score has the structural setup.
Why is Apollo Hospitals share falling?
Pressure on APOLLOHOSP usually starts with the signals the desk watches first, a slower-than-expected hospital ramp or HealthCo losses weighing on consolidated margins, with pricing-cap risk or a de-rating adding to it. The Crack Score levels show the technical picture.
Is APOLLOHOSP a qualifying setup on the BazaarBaazi scanner right now?
On the 2026-07-21 run of the 500-name BazaarBaazi setup scanner, APOLLO HOSPITALS ENTERPRISE LIMITED sits in the Scanned tier with a setup score of 71/100 (technical 100, fundamental 20). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.
Where can I read APOLLO HOSPITALS ENTERPRISE LIMITED's earnings call transcripts?
BazaarBaazi indexes 27 APOLLOHOSP earnings calls going back to 2018-02-28, latest 2026-02-28. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.
What was APOLLO HOSPITALS ENTERPRISE LIMITED's Q4 FY26 net profit?
APOLLO HOSPITALS ENTERPRISE LIMITED reported a net profit of Rs 551 cr for Q4 FY26 (the quarter ended 31 March 2026). The figure is from the company's official NSE filing.
What was APOLLO HOSPITALS ENTERPRISE LIMITED's Q4 FY26 revenue?
APOLLO HOSPITALS ENTERPRISE LIMITED reported revenue of Rs 6,606 cr for Q4 FY26. The figure is from the company's official NSE filing.
How does BazaarBaazi rate APOLLO HOSPITALS ENTERPRISE LIMITED's Q4 FY26 result?
BazaarBaazi gives APOLLO HOSPITALS ENTERPRISE LIMITED's Q4 FY26 result a Result Pulse of 0 out of 100, with a verdict of Insufficient data. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
What has Apollo Hospitals Enterprise Ltd announced recently?
Apollo Hospitals Enterprise Ltd's two most material recent disclosures are an investor meet dated 18 Jul 2026, "Schedule of meet", and a regulatory dated 03 Jul 2026, "Certificate under Regulation 74(5) for the period ended…". Both link to the company's own official filing on the BazaarBaazi stock page.
Has Apollo Hospitals Enterprise Ltd declared a dividend recently?
Yes. Apollo Hospitals Enterprise Ltd filed a dividend disclosure on 20 May 2026, filed as "Record date for the purpose of Dividend is 14-Aug-2026". Any amount shown is the exchange's own record, linked from the BazaarBaazi stock page. A dividend is a declared payout, not a forecast of future returns.
What did Apollo Hospitals Enterprise Ltd's latest board meeting cover?
Apollo Hospitals Enterprise Ltd's most recent board-meeting disclosure on record dated 21 May 2026 reads "Notice of Court Convened General Meeting to be held on Jun 24, 2026". That is the agenda as filed with the exchange, linked from the BazaarBaazi stock page, and BazaarBaazi adds no claim of its own to it.
Has Apollo Hospitals Enterprise Ltd's credit rating been updated recently?
Apollo Hospitals Enterprise Ltd filed a credit-rating disclosure on 19 May 2026, recorded with the exchange as "Credit Rating- New". The detail sits in the linked filing on the BazaarBaazi stock page. A rating action is an agency view on debt, separate from the share price.
Related stock views
The names BazaarBaazi reads alongside APOLLOHOSP, each a living view refreshed every end-of-day run.